Please login to the form below

Not currently logged in
Email:
Password:

Almirall appoints first woman to the board

Karin Louise Dorrepaal will serve as an independent board member

Spanish pharmaceutical company Almirall has picked Karin Louise Dorrepaal to sit on its board of directors as an independent board member.

She is the first woman to join the Barcelona-based company's ten member board and has gained extensive international experience in the pharmaceutical sector during her 25 year career.

This includes six years serving as director of global business unit diagnostic imaging and supply chain and procurement at Bayer Pharma and sitting on the board of Schering for two years.

Dorrepaal currently holds non-executive positions in healthcare sector and consultancy companies.

Earlier this month, she was appointed to the supervisory board of German specialty pharma company Paion, where she replaced Grünenthal chief executive Harald Stock. 

Dorrepaal's appointment to the Almirall board will take effect from January 1, 2013, and will be ratified at the company's next annual general meeting.

23rd November 2012

From: Research, Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics